From the comprehensive data, we selected the three-day blood dataset, including six mice, from which the authors had described a mixture of CD4+ T cell clusters expanded by two different anti-tumor therapies, as revealed by a combination of Scaffold Maps (6) and Citrus analysis (7) (Figure 1). The gene discussed is CD4; the disease is neoplasm.